Podcast Episodes
Back to SearchE135: IL17 and a GLP1?
Episode 136
Really interesting study this week comparing the IL17 inhibitor ixekizumab WITH the GLP1 inhibitor tirzepatide to ixekizumab alone. Raises some inter…
10 hours ago
E134: Brepocitinib in Dermatomyositis (VALOR)
Episode 135
Great trial this week looking at brepocitinib in dermatomyositis. Looks like a winner, expect it will be approved. Where it fits in our approach to I…
1 week, 6 days ago
E133: Obinutuzumab for SLE (ALLEGORY)
Episode 134
Good RCT this week, investigating the CD20 B cell inhibitor obinutuzumab for SLE. Sign up for my newsletter if you would like to have a read-along co…
1 month, 1 week ago
E132: Romosozumab vs teriparatide for osteoproosis (STRUCTURE)
Episode 133
Quick podcast this week about a nifty head to head study that I had previously missed. Worth reading if - like me - you're still trying to figure out…
1 month, 3 weeks ago
E131: A Sham-Controlled Sham of a Trial: RESET-RA
Episode 132
Today I cover the recent publication of the RESET-RA study, which evaluated vagal nerve stimulation to treat rheumatoid arthritis. Have a listen in f…
3 months, 1 week ago
E130: Telitacicept for SLE
Episode 131
Surprisingly (unbelievably?) impressive RCT evaluating the Blys/APRIL inhibitor "telitacicept" for patients with SLE (mixed SLE and SLE-LN). Very cur…
4 months, 1 week ago
E129: Long Term Routine Laboratory Monitoring in RA
Episode 130
Ever wonder how often you really need to check "monitoring" labs? If so then this is the podcast for you! Bryant England mentioned this during his ex…
4 months, 3 weeks ago
E128: Nerandomilast for Autoimmune ILD (FIBRONEER-ILD)
Episode 129
Covering a very interesting study this week, which investiaged the PDE4B inhibitor nerandomilast for patients with progressive pulmonary fibrosis (sp…
5 months, 2 weeks ago
E127: TNFs and All That CHF
Episode 128
Another episode looking into safety this week! Tackling that pesky issue of TNFs and CHF. Be sure to subscribe to my newsletter and check out the pap…
7 months, 1 week ago
E126: Risk Signals, JAKs, and SELECTIVE-ity
Episode 127
Covering an interesting but ultimately disappointing post hoc study of multiple upadacitinib trials in RA. Initially some hope for clarity in the "Do…
7 months, 3 weeks ago